Pfizer COVID-19 vaccine appointments are available to our patients. Sign up for Connect today to schedule your vaccination.

Four NYC Medical Centers Receive New NIH Precision Medicine Grant

NEW YORK, NY, July 8, 2016 — Columbia University Medical Center (CUMC) and Weill Cornell Medicine, in collaboration with NewYork-Presbyterian and NYC Health + Hospitals/Harlem, have been awarded a grant from the NIH for approximately $4 million in fiscal year 2016 to enroll participants in the Cohort Program of President Barack Obama's Precisi

Not just a shot in the dark

In many ways, it’s a science success story: 8-year-old boy with a rare form of brain cancer is treated by one of the world’s leading experts in the disease, who collaborates with a pioneering precision medicine institute to sequence his cancer and create a first-of-its-kind tumor model replica in the lab, allowing for further analysis and treatment testing without risk of harm to the child.

New Gene Therapy Protects Against Peanut Allergy

A new gene therapy developed by scientists at Weill Cornell Medicine could eventually prevent the life-threatening effects of peanut allergy with just a single dose, according to a new pre-clinical study.

The Leukemia & Lymphoma Society Names John P. Leonard, MD of Weill Cornell Medicine and NewYork-Presbyterian its 2016 Manhattan Light The Night Corporate Chair

 The New York City Chapter of The Leukemia & Lymphoma Society (LLS) has announced John P. Leonard, MD, of Weill Cornell Medicine and NewYork-Presbyterian as its 2016 Manhattan Light The Night® corporate chair. Light The Night is LLS's largest annual fundraising event held each fall to find cures and provide access to treatments for blood cancer patients.

Scientists Propose a Framework for More Comprehensive Assessment of Medical Device Safety and Efficacy

Every medicine we take has been extensively trialled to prove it is safe and it works, but the same standards do not necessarily apply to medical devices like joint replacements, surgical mesh or pacemakers. Now, a group of researchers led by Oxford University and Weill Cornell Medicine has proposed a new framework to make sure that such devices get better scrutiny.

Dr. David E. Cohen Named Chief of Division of Gastroenterology and Hepatology at Weill Cornell Medicine and NewYork-Presbyterian/Weill Cornell Medical Center

 Dr. David E. Cohen, an internationally renowned physician-scientist who combines clinical care as a hepatologist with research focused on obesity-related liver disease, has been named chief of the Division of Gastroenterology and Hepatology at Weill Cornell Medicine and NewYork-Presbyterian/Weill Cornell Medical Center, effective July 1.

Innovative Immunotherapy More Effective in Treating an Aggressive Lymphoma than Chemotherapy

A drug that recruits immune cells to fight an aggressive form of lymphoma that disproportionately affects minorities in the United States appears to be more effective than chemotherapy, according to new research from Weill Cornell Medicine and NewYork-Presbyterian.

Mathematical Analysis of Drug Resistance in Chronic Leukemia

The rate at which genetically mutated cancer cells grow may help explain why patients with a common form of leukemia develop treatment resistance, according to new research led by a Weill Cornell Medicine investigator. The findings demonstrate how mutations that arise before treatment begins can influence how the disease responds to therapies, and underscores the need to design regimens that can preempt resistance.

Study Describes Potential Transmission of Non-Genetic Behavioral Traits to New Generations

Individual symptoms of psychiatric disorders, such as anxiety, avoidance and a heightened response to stress, can be transmitted from mother to child and even grandchild by multiple non-genetic mechanisms, a new study by investigators at Weill Cornell Medicine and other institutions shows.

Erica: Home Is Where the Heart Is

As a cardiologist, Dr. Erica Jones has seen more people die from their first heart attack than she cares to admit. Many times these cases are her patients, her friends and her colleagues. Most tragic of it all, she said, is that these deaths are preventable.